Suppr超能文献

一种新型抗心律失常药物西苯唑啉对兔窦房结、心房、心室及浦肯野细胞电位的影响,该药物可防止缺氧时动作电位缩短。

Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia.

作者信息

Millar J S, Vaughan Williams E M

出版信息

Br J Pharmacol. 1982 Mar;75(3):469-78. doi: 10.1111/j.1476-5381.1982.tb09163.x.

Abstract

1 The effects of cibenzoline (UP 339-01), a new anti-arrhythmic drug, have been investigated in various cardiac tissues. 2 UP 339-01 produced a bradycardia, due partly to prolongation of the intracellularly recorded sinus node action potential duration (APD) and partly to depression of the maximum rate of depolarization (MRD). The slope of the slow diastolic depolarization was not significantly reduced. 3 UP 339-01 was not a beta-adrenoceptor antagonist. 4 UP 339-01 was negatively inotropic, and shifted the relation between [Ca2+]o and force of contractions to the right, and increased A-H conduction time. It was concluded that UP 339-01 restricted slow inward current. 5 In all cardiac tissues depolarized by fast inward current, UP 339-01 caused a reduction in MRD and conduction velocity. The reduction was similar in atrial muscle, His and terminal Purkinje fibres, but in papillary muscle the effect was about half as great. On desheathed frog nerve UP 339-01 had a local anaesthetic potency slightly greater than that of procaine. 6 APD was significantly prolonged in a dose-related manner in ventricular muscle but to a lesser extent in the bundle of His and atrial tissue. In terminal Purkinje fibres APD50 and APD90 were unaltered, but the transient outward current ("notch') was abolished, resulting in a lengthening of APD20. 7 The effective and functional refractory periods of the A-V node and right bundle branch were both lengthened by UP 339-01 in a dose-related manner, and the difference between them was greatly increased. 8 UP 339-01 (2.63 microM) completely prevented the shortening of APD90 induced by hypoxia, and the shortening of APD50 and APD20 was much attenuated. There was no protection against hypoxic depression of contractions. 9 It was concluded that UP 339-01 is a highly active class 1 anti-arrhythmic agent with additional class 3 and 4 properties.

摘要
  1. 新型抗心律失常药物西苯唑啉(UP 339 - 01)的作用已在多种心脏组织中进行了研究。2. UP 339 - 01引起心动过缓,部分原因是细胞内记录的窦房结动作电位时程(APD)延长,部分原因是最大去极化速率(MRD)降低。舒张期缓慢去极化的斜率未显著降低。3. UP 339 - 01不是β - 肾上腺素能受体拮抗剂。4. UP 339 - 01具有负性肌力作用,使细胞外钙浓度([Ca2 +]o)与收缩力之间的关系右移,并延长A - H传导时间。得出的结论是,UP 339 - 01限制慢内向电流。5. 在所有由快内向电流去极化的心脏组织中,UP 339 - 01导致MRD和传导速度降低。心房肌、希氏束和浦肯野纤维终末的降低程度相似,但在乳头肌中,这种作用约为前者的一半。在剥除鞘膜的蛙神经上,UP 339 - 01的局部麻醉效能略高于普鲁卡因。6. 在心室肌中,APD以剂量相关的方式显著延长,但在希氏束和心房组织中延长程度较小。在浦肯野纤维终末,APD50和APD90未改变,但瞬时外向电流(“切迹”)消失,导致APD20延长。7. UP 339 - 01以剂量相关的方式延长房室结和右束支的有效不应期和功能不应期,且两者之间的差异显著增大。8. UP 339 - 01(2.63微摩尔)完全阻止了缺氧诱导的APD90缩短,APD50和APD20的缩短也明显减轻。但对缺氧引起的收缩力降低无保护作用。9. 得出的结论是,UP 339 - 01是一种具有额外Ⅲ类和Ⅳ类特性的高活性Ⅰ类抗心律失常药物。

相似文献

引用本文的文献

6
Adverse effects of class I antiarrhythmic drugs.I类抗心律失常药物的不良反应。
Drug Saf. 1997 Jul;17(1):8-36. doi: 10.2165/00002018-199717010-00002.

本文引用的文献

1
Antifibrillatory action.抗纤颤作用。
J Physiol. 1962 Mar;160(3):470-82. doi: 10.1113/jphysiol.1962.sp006860.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验